Details for 2011758014
Up to date per 01.04.2026
Actions
Details for 2011758014
Granted/Registered
European Patent
10.07.2013 A
09.03.2022 B1
31.08.2010
US
378826 P
A61K 39/39 20060101AFI20120320BHEP
Owner
GlaxoSmithKline Biologicals SARue de l'Institut 89 1330 RixensartBE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
GEALL, Andrewc/o Novartis Vaccines And Diagnostic Inc. PO Box 8097 Emeryville, CA 94662-8097US
VERMA, Ayushc/o Novartis Vaccines And Diagnostic Inc. PO Box 8097 Emeryville, CA 94662-8097US
Information about Fees